Strengthening the Foundations
This week, I take profits from biotech and Japanese banks, and shift into two of the world’s greatest companies.
This week, I take profits from biotech and Japanese banks, and shift into two of the world’s greatest companies.
Chemicals are rallying as part of the global recovery in cyclical stocks. We researched the opportunities and have found another gem.
A shareholder vote is near for one of our long-term holdings. Advice is laid out below.
This week, ByteTree held a must-watch conversation with none other than Chris Wood, the Global Head of Equity Strategy at
Bitcoin’s ByteTrend Score remains zero, after a severe fall in recent days. This move has been linked to the general malaise in tech stocks, which makes sense to me.
Listed private equity companies have come under pressure. The sector touts a good story, and forecasts a strong IPO market in 2026, yet the businesses behind them, which hold large stakes in private companies, are not yet celebrating.